Ablative zone size created by radiofrequency ablation with and without chemoembolization in small hepatocellular carcinomas

Jpn J Radiol. 2012 Aug;30(7):553-9. doi: 10.1007/s11604-012-0087-2. Epub 2012 May 19.

Abstract

Purpose: We retrospectively evaluated whether combined use of chemoembolization expands ablative zone sizes created by radiofrequency (RF) ablation in patients with small hepatocellular carcinomas (HCCs).

Materials and methods: Fifty-seven patients treated with single RF ablation for solitary HCC measuring ≤2 cm were assessed. RF ablation alone was done in nine patients and in 48 patients following chemoembolization, with an interval of 0 days in 6, 1-14 days in 27, 15-28 days in 6, and ≥4 weeks in 9. Ablative zone sizes, disappearance of tumor enhancement, and creation of sufficient ablative margins (>5 mm) were evaluated on contrast-enhanced computed tomography (CT) images.

Results: Both mean long-axis (4.2-4.7 vs. 3.6 ± 0.4 cm, p < 0.04) and short-axis (3.3-3.8 vs. 2.3 ± 0.5 cm, p < 0.03) diameters were expanded significantly when RF ablation was done until 4 weeks after chemoembolization than with RF ablation alone. Tumor enhancement disappeared in all patients. Frequency of achieving sufficient ablative margins was significantly higher when RF ablation was done until 4 weeks after chemoembolization than with RF ablation alone (74.0-83.3 vs. 22.2 %, p < 0.05).

Conclusion: Ablative zones created by RF ablation with chemoembolization become larger than RF ablation alone, leading to secure ablative margins.

MeSH terms

  • Aged
  • Analysis of Variance
  • Carcinoma, Hepatocellular / diagnostic imaging
  • Carcinoma, Hepatocellular / therapy*
  • Catheter Ablation / methods*
  • Chemoembolization, Therapeutic / methods*
  • Combined Modality Therapy
  • Contrast Media
  • Female
  • Humans
  • Liver Function Tests
  • Liver Neoplasms / diagnostic imaging
  • Liver Neoplasms / therapy*
  • Male
  • Radiography, Interventional
  • Retrospective Studies
  • Statistics, Nonparametric
  • Tomography, X-Ray Computed
  • Treatment Outcome

Substances

  • Contrast Media